Searched for
DOMESTIC FORMULATION BUSINESS
Pest resistance is forcing India’s crop-protection firms to rethink product strategies: Insecticides India MDResistance to chemicals and formulations is an evolving challenge, particularly in crops where the same pest pressures persist over multipl...- These mid-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of over 25%, according to analystsWhat is needed in the markets these days is realism. Not fear or gloom, but a clear-eyed acceptance of where things actually stand. Realism...
- India’s media industry needs to move from scale to value: PrabhatPrabhat emphasized the need for India's media and entertainment industry to create enduring economic value. He noted that overwhelming scal...
- India orders crackdown on nicotine pouches, citing health risks, letter showsIndia has directed states to take enforcement action against the sale of nicotine pouches, citing public health and risks to children. The ...
- The big winners from India's coffee craze may not sell coffee at allIndia’s coffee culture is expanding beyond cafes and coffee chains, creating opportunities across beauty, homeware, luxury hospitality, whi...
- These mid-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of over 25%, according to analystsThere are times when a watchlist is more important than a buy list. But if you still insist on putting money in the market, look at fundame...
- MF Tracker: HDFC Pharma & Healthcare Fund tops equity MFs at 25% in 1 year. Should investors chase the rally?HDFC Pharma and Healthcare Fund recorded an impressive 25% return in the last year, surpassing its category average across various time fra...
- Can India build its own Big Four? The battle moves to the rulebookIndia is moving to reshape its accounting sector as ICAI prepares Chartered Accountants Act changes aimed at enabling larger domestic firms...
- 5 stocks with consistent score improvement and upside potential of up to 22% in 1 year, according to analystsGiven the current situation both globally and domestically, one can expect more headwinds in the market. There is, on the domestic front, a...
- MFs raise healthcare bets for 4th straight month to 71-month high. Should investors follow?Mutual funds raised their healthcare allocation for the fourth straight month in August 2026 to 8.4%, the highest in 71 months. Experts att...
- BRICS adopts New Delhi Declaration: Inside the 140-point document on Global South's ambitionsBRICS leaders adopted the New Delhi Declaration at the 18th summit, reaffirming their commitment to cooperation, multilateralism and a more...
- Tata Capital Healthcare Fund to exit Linux Laboratories as ChrysCapital buys 20-25% stakePrivate equity firm ChrysCapital is set to acquire a significant stake in Linux Laboratories. This deal will see existing investor Tata Cap...
- How PGIM India's Rs 112 crore Healthcare Fund picks CDMO stocks to generate alphaPGIM India Healthcare Fund generated a 22% return over the past year by over-allocating to high-growth segments like CDMO, specialty pharma...
- RPG Life Sciences to deploy Rs 500 crore in next 12 months to bolster manufacturing, API capabilitiesRPG Life Sciences plans to deploy Rs 500 crore over the next 12 months to expand manufacturing and API capabilities through strategic acqui...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsIn the equity market, it is generally good to keep one eye on risk management. But there are times when it becomes a must-do. We are curren...
- China-US spat at G20 largely came down to dispute over one wordA G20 finance meeting saw US and Chinese officials disagree over trade language. The core dispute centered on the phrase "non-market" polic...
- When volatility rises, will you panic or buy? Depends on the watchlist you build now: 5 large-cap stocks with upside potential of up to 32%Another worry has emerged for the markets, and it will drive the narrative in the short term. As usual, it comes from the US. The US Fed ha...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsGiven the possibility of hostilities resuming in the Gulf region, focus on risk management in the market. Why? Because fresh hostilities wi...
- Korean manufacturers have stopped testing the Indian market. They are now committing to it.The shift from testing a market to supplying it changes what an exporter must bring-and Korean small manufacturers are arriving with certif...
- Siguler Guff raises $500 mn for India mid-market private equity strategySiguler Guff has secured $500 million for India's mid-market businesses. The capital will fund founder and family-owned companies in key se...
Load More
